[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE470477B - Salva innehållande fibronektin för behandling av sår - Google Patents

Salva innehållande fibronektin för behandling av sår

Info

Publication number
SE470477B
SE470477B SE9202895A SE9202895A SE470477B SE 470477 B SE470477 B SE 470477B SE 9202895 A SE9202895 A SE 9202895A SE 9202895 A SE9202895 A SE 9202895A SE 470477 B SE470477 B SE 470477B
Authority
SE
Sweden
Prior art keywords
weight
ointment
ointment according
wound
mixture
Prior art date
Application number
SE9202895A
Other languages
English (en)
Swedish (sv)
Other versions
SE9202895L (sv
SE9202895D0 (sv
Inventor
Per E Alm
Pia Alm
Original Assignee
Procell Bioteknik Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of SE9202895D0 publication Critical patent/SE9202895D0/xx
Priority to SE9202895A priority Critical patent/SE470477B/sv
Application filed by Procell Bioteknik Ab filed Critical Procell Bioteknik Ab
Priority to AT93850180T priority patent/ATE190500T1/de
Priority to ES93850180T priority patent/ES2146223T3/es
Priority to DE69328065T priority patent/DE69328065T2/de
Priority to EP93850180A priority patent/EP0592380B1/en
Priority to AU48801/93A priority patent/AU4880193A/en
Priority to CA002107598A priority patent/CA2107598A1/en
Priority to US08/131,149 priority patent/US5733870A/en
Priority to JP24948193A priority patent/JP3715659B2/ja
Publication of SE9202895L publication Critical patent/SE9202895L/
Publication of SE470477B publication Critical patent/SE470477B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9202895A 1992-10-05 1992-10-05 Salva innehållande fibronektin för behandling av sår SE470477B (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9202895A SE470477B (sv) 1992-10-05 1992-10-05 Salva innehållande fibronektin för behandling av sår
AT93850180T ATE190500T1 (de) 1992-10-05 1993-09-21 Fibronektin enthaltende salbe zur behandlung von epithelialen verletzungen
ES93850180T ES2146223T3 (es) 1992-10-05 1993-09-21 Unguento que contiene fibronectina para el tratamiento de lesiones epiteliales.
DE69328065T DE69328065T2 (de) 1992-10-05 1993-09-21 Fibronektin enthaltende Salbe zur Behandlung von epithelialen Verletzungen
EP93850180A EP0592380B1 (en) 1992-10-05 1993-09-21 Fibronectin-containing ointment for treatment of epithelial lesions
AU48801/93A AU4880193A (en) 1992-10-05 1993-10-01 Ointment for treatment of epithelial lesions
US08/131,149 US5733870A (en) 1992-10-05 1993-10-04 Ointment for treatment of epithelial lesions
CA002107598A CA2107598A1 (en) 1992-10-05 1993-10-04 Ointment for treatment of epithelial lesions
JP24948193A JP3715659B2 (ja) 1992-10-05 1993-10-05 上皮病巣の治療用軟膏

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9202895A SE470477B (sv) 1992-10-05 1992-10-05 Salva innehållande fibronektin för behandling av sår

Publications (3)

Publication Number Publication Date
SE9202895D0 SE9202895D0 (sv) 1992-10-05
SE9202895L SE9202895L (sv) 1994-04-06
SE470477B true SE470477B (sv) 1994-05-24

Family

ID=20387373

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9202895A SE470477B (sv) 1992-10-05 1992-10-05 Salva innehållande fibronektin för behandling av sår

Country Status (9)

Country Link
US (1) US5733870A (ja)
EP (1) EP0592380B1 (ja)
JP (1) JP3715659B2 (ja)
AT (1) ATE190500T1 (ja)
AU (1) AU4880193A (ja)
CA (1) CA2107598A1 (ja)
DE (1) DE69328065T2 (ja)
ES (1) ES2146223T3 (ja)
SE (1) SE470477B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528483B2 (en) 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
GB9705340D0 (en) * 1997-03-14 1997-04-30 Nycomed Imaging As Compositions
FR2777461B1 (fr) * 1998-04-16 2003-04-25 Ceetal Sa Lab Agent de soin du trayon et procede de preparation
US6917095B1 (en) 2000-05-30 2005-07-12 Altera Corporation Integrated radio frequency circuits
JP4313033B2 (ja) * 2002-12-27 2009-08-12 株式会社日本点眼薬研究所 眼科用治療組成物
WO2004089357A2 (en) * 2003-04-02 2004-10-21 Regents Of The University Of Minnesota Anti-fungal formulation of triterpene and essential oil

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017615A (en) * 1970-10-29 1977-04-12 Syntex Corporation Propylene carbonate ointment vehicle
JPS5976007A (ja) * 1982-10-22 1984-04-28 Shiseido Co Ltd 化粧料
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
JPS61103836A (ja) * 1984-10-24 1986-05-22 Green Cross Corp:The フイブロネクチン製剤
FI854634A0 (fi) * 1985-11-22 1985-11-22 Labsystems Oy Foerfarande foer bestaemning av proteolytisk aktivitet.
JPS62123112A (ja) * 1985-11-22 1987-06-04 Sunstar Inc 軟膏基剤
US4837019A (en) * 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
US4929442A (en) * 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
US5036056A (en) * 1987-07-08 1991-07-30 Martin Kludas Methods for treating damaged corneal, uterine, or cartilage tissue
US5246708A (en) * 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
US5053388A (en) * 1987-11-09 1991-10-01 Chiron Ophthalmics, Inc. Wound healing composition and method
US5055298A (en) * 1987-12-01 1991-10-08 Chemisches Laboratorium Dr. Kurt Richter Gmbh Cosmetic composition comprising an extracellular connective tissue matrix
US4939135A (en) * 1988-10-03 1990-07-03 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation
US5196185A (en) * 1989-09-11 1993-03-23 Micro-Collagen Pharmaceutics, Ltd. Collagen-based wound dressing and method for applying same
JP3088744B2 (ja) * 1990-05-28 2000-09-18 日本ケミカルリサーチ株式会社 フィブロネクチン組成物

Also Published As

Publication number Publication date
EP0592380B1 (en) 2000-03-15
SE9202895L (sv) 1994-04-06
ATE190500T1 (de) 2000-04-15
JPH06199684A (ja) 1994-07-19
AU4880193A (en) 1994-04-21
CA2107598A1 (en) 1994-04-06
SE9202895D0 (sv) 1992-10-05
EP0592380A1 (en) 1994-04-13
US5733870A (en) 1998-03-31
DE69328065D1 (de) 2000-04-20
DE69328065T2 (de) 2000-11-02
ES2146223T3 (es) 2000-08-01
JP3715659B2 (ja) 2005-11-09

Similar Documents

Publication Publication Date Title
US4012504A (en) Iodine mineral oil solution for preventing bovine mastitis
US4670263A (en) Nontoxic, germicide, and healing compositions
AU2006207326B2 (en) Anthelmintic composition
DE60038106T3 (de) Anthelmintische zusammensetzungen
SE470477B (sv) Salva innehållande fibronektin för behandling av sår
JPS59167511A (ja) 殺外部寄生虫製剤、その製造法および外部寄生虫の防除法
CN106075436B (zh) 一种不含抗生素的抗幽门螺杆菌口服制剂
DK156196B (da) Fremgangsmaade til fremstilling af et tetramisol eller lavamisol paahaeldningspraeparat
US4466959A (en) Preparation for udder care and disinfection for dairy animals
Halliday Variations in immunoglobulin concentrations in Finnish× Dorset Horn lambs
AU701697B2 (en) Aqueous compositions containing ciprofloxacine, and related use and process
AU2003293685B2 (en) Combination product for controlling insect pests
CN108670948A (zh) 一种纳米级微囊单分子聚维酮碘溶液及其制备方法
US4912138A (en) Pharmaceutical preparation containing thiamphenicol for veterinary use
HU198843B (en) Process for producing veterinary compositions with disinfecting and antiinflammatory action, comprising natural active ingredient and suitable particularly for treating mastitis
Aitken et al. Plasma levels following administration of sodium meclofenamate by various routes
US4282253A (en) Topical prophylaxis against schistosomiasis
RU2599489C1 (ru) Средство для обработки вымени коров
Swales Controlling Caecal Coccidiosis in Chicks
RU2663293C1 (ru) Способ лечения острых лактационных маститов у свиноматок
Erhardt et al. Veränderungen in der bakteriostatischen Aktivität des Lactoferrins während der Laktation sowie nach experimenteller Infektion der Milchdrüse mit Staphylococcus aureus
JPH1149672A (ja) 創傷治療用外用剤
McHardy et al. Comparison of gloxazone, an effective but toxic anaplasmacide, with imidocarb dihydrochloride
McKinzie et al. Milk iodine residues: AMS versus conventional
US20240316244A1 (en) Formulation for healing wounds

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 9202895-0

Format of ref document f/p: F

NUG Patent has lapsed